RT Journal Article
SR Electronic
T1 COVID-19 epidemic scenarios into 2021 based on observed key superspreading events
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.04.14.21255436
DO 10.1101/2021.04.14.21255436
A1 Santana-Cibrian, Mario
A1 Acuña-Zegarra, M. Adrian
A1 Rodríguez, Carlos E.
A1 Mena, Ramsés H.
A1 Velasco-Hernandez, Jorge X.
YR 2021
UL http://medrxiv.org/content/early/2021/06/02/2021.04.14.21255436.abstract
AB Key high transmission dates for the year 2020 are used to create scenarios of the evolution of the COVID-19 pandemic in several states of Mexico for 2021. These scenarios are obtained through the estimation of a time-dependent contact rate, where the main assumption is that disease behavior is heavily determined by the mobility and social activity of the population during holidays and other important calendar dates. First, changes in the effective contact rate on predetermined dates of 2020 are estimated. Then, this information is used to propose different scenarios for the number of cases and deaths for 2021. The fundamental assumptions behind this methodology are that the effective contact rate incorporates the main superspreading transmission events during last year, that each region has an independent epidemic not explicitly interconnected with other regions and, finally, that there are no new highly transmissible SARS-CoV-2 variants active during the timeline of the forecasts. Also, several levels of vaccination are considered to analyze their impact on the projections of the epidemic curve. The objective is to generate a range of scenarios that could be useful to evaluate the possible evolution of the epidemic and its likely impact on incidence and mortality.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NoneAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data used in this work is publicly available. https://www.gob.mx/salud/documentos/datos-abiertos-152127